0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Building a Risk Scoring Model for ARDS in Lung Adenocarcinoma Patients Using Machine Learning Algorithms

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          ABSTRACT

          Lung adenocarcinoma (LUAD), the predominant form of non‐small‐cell lung cancer, is frequently complicated by acute respiratory distress syndrome (ARDS), which increases mortality risks. Investigating the prognostic implications of ARDS‐related genes in LUAD is crucial for improving clinical outcomes. Data from TCGA, GEO and GTEx were used to identify 276 ARDS‐related genes in LUAD via differential expression analysis. Univariate Cox regression, consensus clustering and machine learning algorithms were used to develop a prognostic risk scoring model. Functional enrichment, immune infiltration analyses, copy number variations and mutational burdens were examined, and the results were validated at the single‐cell level. ARDS‐related genes significantly impact the prognosis of LUAD patients. A machine learning‐based risk scoring model accurately predicted survival rates. Functional enrichment and immune infiltration analyses revealed that these genes are primarily involved in cell cycle regulation and immune cell infiltration. Single‐cell expression data supported these findings, and the assessments of copy number variations and mutational burdens highlighted distinct genetic characteristics. This study establishes the prognostic relevance of ARDS‐associated genes in LUAD and provides potential biomarkers for personalized therapy and prognosis. Future studies will validate these findings and explore their clinical applications.

          Related collections

          Most cited references39

          • Record: found
          • Abstract: found
          • Article: not found

          Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries.

          Limited information exists about the epidemiology, recognition, management, and outcomes of patients with the acute respiratory distress syndrome (ARDS).
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker

            Tumor mutational burden (TMB) reflects cancer mutation quantity. Mutations are processed to neo-antigens and presented by major histocompatibility complex (MHC) proteins to T cells. To evade immune eradication, cancers exploit checkpoints that dampen T cell reactivity. Immune checkpoint inhibitors (ICIs) have transformed cancer treatment by enabling T cell reactivation; however, response biomarkers are required, as most patients do not benefit. Higher TMB results in more neo-antigens, increasing chances for T cell recognition, and clinically correlates with better ICI outcomes. Nevertheless, TMB is an imperfect response biomarker. A composite predictor that also includes critical variables, such as MHC and T cell receptor repertoire, is needed.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The 2021 WHO Classification of Lung Tumors: Impact of advances since 2015

              The 2021 WHO Classification of Thoracic Tumours was published earlier this year, with classification of lung tumors being one of the chapters. The principles remain those of using morphology first, supported by immunohistochemistry, and then molecular techniques. In 2015, there was particular emphasis on using immunohistochemistry to make classification more accurate. In 2021, there is greater emphasis throughout the book on advances in molecular pathology across all tumor types. Major features within this edition are (1) broader emphasis on genetic testing than in the 2015 WHO Classification; (2) a section entirely dedicated to the classification of small diagnostic samples; (3) continued recommendation to document percentages of histologic patterns in invasive nonmucinous adenocarcinomas, with utilization of these features to apply a formal grading system, and using only invasive size for T-factor size determination in part lepidic nonmucinous lung adenocarcinomas as recommended by the eighth edition TNM classification; (4) recognition of spread through airspaces as a histologic feature with prognostic significance; (5) moving lymphoepithelial carcinoma to squamous cell carcinomas; (6) update on evolving concepts in lung neuroendocrine neoplasm classification; (7) recognition of bronchiolar adenoma/ciliated muconodular papillary tumor as a new entity within the adenoma subgroup; (8) recognition of thoracic SMARCA4-deficient undifferentiated tumor; and (9) inclusion of essential and desirable diagnostic criteria for each tumor.
                Bookmark

                Author and article information

                Contributors
                13955220058@139.com
                Journal
                J Cell Mol Med
                J Cell Mol Med
                10.1111/(ISSN)1582-4934
                JCMM
                Journal of Cellular and Molecular Medicine
                John Wiley and Sons Inc. (Hoboken )
                1582-1838
                1582-4934
                10 December 2024
                December 2024
                : 28
                : 23 ( doiID: 10.1111/jcmm.v28.23 )
                : e70280
                Affiliations
                [ 1 ] Department of Emergency Medicine, Bengbu Third People's Hospital Bengbu Medical University Bengbu Anhui Province China
                [ 2 ] Department of Neurology, Bengbu Third People's Hospital Bengbu Medical University Bengbu Anhui Province China
                [ 3 ] Department of Pathology Bengbu Medical University Bengbu Anhui Province China
                Author notes
                [*] [* ] Correspondence:

                Liang Zhang ( 13955220058@ 123456139.com )

                Author information
                https://orcid.org/0009-0002-6547-6600
                Article
                JCMM70280 JCMM-09-2024-032.R1
                10.1111/jcmm.70280
                11629804
                39656479
                dfd5d19a-c28e-4091-9730-ecb70839d05a
                © 2024 The Author(s). Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 17 October 2024
                : 05 September 2024
                : 22 October 2024
                Page count
                Figures: 11, Tables: 0, Pages: 16, Words: 6500
                Funding
                Funded by: Department of Education of Anhui Province‐Anhui Province Higher School Scientific Research Project
                Award ID: 2023AH0519911
                Funded by: Bengbu Third People’s Hospital affiliated with Bengbu Medical University‐Culture Programme
                Award ID: BBSYpyky202307011
                Categories
                Original Article
                Original Article
                Custom metadata
                2.0
                December 2024
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.1 mode:remove_FC converted:10.12.2024

                Molecular medicine
                acute respiratory distress syndrome,biomarkers,lung adenocarcinoma,risk scoring model

                Comments

                Comment on this article